ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

12
Analysis
Health CareUnited States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
Refresh
30 Apr 2024 17:05

End of Mandatory Lock-Up Periods for 54 Companies in Korea in May 2024

We discuss the end of the mandatory lock-up periods for 54 stocks in Korea in May 2024, among which 4 are in KOSPI and 50 are in KOSDAQ.

Logo
357 Views
Share
bullishGigaVis
11 Jan 2024 19:35

An Early Look at the Potential KOSDAQ150 Rebalance Candidates in June 2024

In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024. Potential inclusion candidates include LS Materials,...

Logo
235 Views
Share
19 Feb 2018 10:27

Korean IPOs - Evidence-Based Analysis & The Whiplash Effect

In this report, we provide evidence-based analysis of using key criteria such as the IPO price determined at high/low end of the IPO price range...

Logo
161 Views
Share
21 Dec 2017 08:14

StubWorld - Set-Up & Unwind Extremes: AVIC, Kolon

This week I briefly look at: Avic International Holdings Ltd (161 HK), again, as investors take-profit while 69.7%-held subsidiary Shennan Circuits...

Logo
526 Views
Share
25 Nov 2017 21:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
500 Views
Share
x